A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas
Clinical trial NCT00313313 · COMPLETED
Trial details
- NCT number
- NCT00313313
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-01
- Primary completion
- 2007-09-01
- Enrollment
- 768
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.